AbbVie
ABBV
#35
Rank
$277.34 B
Marketcap
$157.06
Share price
-0.76%
Change (1 day)
11.27%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) Fails to deliver data

Key failure to deliver metrics for AbbVie:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for AbbVie (ABBV) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for AbbVie (ABBV) - since 2013

Volume in USD (price x number of shares), data since 2013

AbbVie (ABBV) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$10.85 M-95.26%
2023$0.22 B-63.52%
2022$0.62 B629.28%
2021$86.13 M-77.97%
2020$0.39 B85.64%
2019$0.21 B-52.97%
2018$0.44 B269.88%
2017$0.12 B-48.45%
2016$0.23 B-37.53%
2015$0.37 B-44.13%
2014$0.67 B2387.79%
2013$27.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$10.32 M$0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA
$56.64 M$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
$52.25 M$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
$22.53 M$74.47 M๐Ÿ‡บ๐Ÿ‡ธ USA
$3.99 M$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
$0.23 B$0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA
$88.62 M$0.16 B๐Ÿ‡ฌ๐Ÿ‡ง UK
$18.31 M$24.09 M๐Ÿ‡ฌ๐Ÿ‡ง UK
$15.31 M$34.27 M๐Ÿ‡บ๐Ÿ‡ธ USA